135 related articles for article (PubMed ID: 25301050)
1. CXCR-4 and COX-2 expression in basal cell carcinomas and well-differentiated squamous cell carcinomas of the skin; their relationship with tumor invasiveness and histological subtype.
Sivrikoz ON; Uyar B; Dağ F; Taşlı F; Sanal SM
Turk Patoloji Derg; 2015; 31(1):30-5. PubMed ID: 25301050
[TBL] [Abstract][Full Text] [Related]
2. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
3. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
Seleit I; Bakry OA; Samaka RM; Malak MA
Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
[TBL] [Abstract][Full Text] [Related]
6. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
7. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
8. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
[TBL] [Abstract][Full Text] [Related]
10. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
11. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma with myoepithelial differentiation.
Zheng S; Guo Y; Mones JM
Am J Dermatopathol; 2011 Dec; 33(8):863-6. PubMed ID: 21885942
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
Culhaci N; Metin K; Copcu E; Dikicioglu E
BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
[TBL] [Abstract][Full Text] [Related]
15. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Wagoner J; Keehn C; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor necrosis factor-related apoptosis-inducing ligand death receptors DR4 and DR5 in human nonmelanoma skin cancer.
Omran OM; Ata HS
Am J Dermatopathol; 2014 Sep; 36(9):710-7. PubMed ID: 24212133
[TBL] [Abstract][Full Text] [Related]
17. Pattern of development of basal versus squamous cell carcinoma.
Shemesh S; Spencer JM; Phelps RG
J Drugs Dermatol; 2006 Jan; 5(1):40-4. PubMed ID: 16468291
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions.
He X; Wei Q; Zhang X; Xiao J; Jin X; Zhu Y; Cui B; Ning G
Pathol Res Pract; 2010 Oct; 206(10):712-5. PubMed ID: 20646838
[TBL] [Abstract][Full Text] [Related]
19. Patterns of epidermal growth factor receptors in basal and squamous cell carcinoma.
Springer EA; Robinson JK
J Dermatol Surg Oncol; 1991 Jan; 17(1):20-4. PubMed ID: 1991877
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma.
Hashimoto N; Inayama M; Fujishima M; Shiozaki H
Hepatogastroenterology; 2007; 54(75):758-60. PubMed ID: 17591056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]